tiprankstipranks
Trending News
More News >
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
US Market

ACADIA Pharmaceuticals (ACAD) Ratios

Compare
2,438 Followers

ACADIA Pharmaceuticals Ratios

ACAD's free cash flow for Q3 2025 was $0.92. For the 2025 fiscal year, ACAD's free cash flow was decreased by $ and operating cash flow was $0.16. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.02 2.38 2.42 4.04 6.43
Quick Ratio
2.94 2.32 2.28 3.99 6.35
Cash Ratio
0.72 0.81 0.74 0.91 1.53
Solvency Ratio
0.67 0.53 -0.18 -1.14 -1.03
Operating Cash Flow Ratio
0.56 0.40 0.07 -0.91 -1.31
Short-Term Operating Cash Flow Coverage
16.88 0.00 1.78 0.00 0.00
Net Current Asset Value
$ 662.92M$ 483.36M$ 298.92M$ 320.54M$ 458.60M
Leverage Ratios
Debt-to-Assets Ratio
0.04 0.04 0.08 0.11 0.09
Debt-to-Equity Ratio
0.06 0.07 0.13 0.15 0.12
Debt-to-Capital Ratio
0.06 0.07 0.12 0.13 0.11
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.45 1.62 1.73 1.47 1.29
Debt Service Coverage Ratio
8.89 0.00 -8.30 0.00 0.00
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
<0.01 0.00 <0.01 0.00 0.00
Interest Debt Per Share
0.32 0.31 0.35 0.38 0.40
Net Debt to EBITDA
-1.73 -2.67 1.94 0.24 0.50
Profitability Margins
Gross Profit Margin
91.92%91.46%93.70%98.03%96.05%
EBIT Margin
9.86%8.80%-10.10%-43.23%-35.20%
EBITDA Margin
11.20%10.46%-9.34%-42.84%-34.51%
Operating Profit Margin
23.01%24.10%-10.10%-43.23%-35.20%
Pretax Profit Margin
26.14%26.94%-7.03%-41.27%-34.60%
Net Profit Margin
24.94%23.64%-8.44%-41.76%-34.67%
Continuous Operations Profit Margin
24.94%23.64%-8.44%-41.76%-34.67%
Net Income Per EBT
95.43%87.75%120.08%101.19%100.21%
EBT Per EBIT
113.59%111.82%69.55%95.46%98.29%
Return on Assets (ROA)
19.63%19.07%-8.18%-36.74%-23.98%
Return on Equity (ROE)
32.27%30.90%-14.19%-53.94%-31.04%
Return on Capital Employed (ROCE)
24.73%29.11%-14.83%-48.38%-28.22%
Return on Invested Capital (ROIC)
23.32%25.22%-14.56%-47.42%-27.83%
Return on Tangible Assets
21.42%21.20%-8.97%-36.74%-23.98%
Earnings Yield
6.38%7.45%-1.19%-8.39%-4.48%
Efficiency Ratios
Receivables Turnover
7.51 9.15 7.10 8.20 7.41
Payables Turnover
3.89 5.05 2.61 0.80 2.78
Inventory Turnover
2.91 3.73 1.28 1.53 2.43
Fixed Asset Turnover
19.62 18.86 12.86 8.40 7.30
Asset Turnover
0.79 0.81 0.97 0.88 0.69
Working Capital Turnover Ratio
1.55 2.12 1.95 1.14 0.85
Cash Conversion Cycle
80.32 65.57 197.30 -174.86 68.43
Days of Sales Outstanding
48.60 39.90 51.43 44.51 49.26
Days of Inventory Outstanding
125.57 97.89 285.89 238.26 150.28
Days of Payables Outstanding
93.85 72.21 140.02 457.63 131.12
Operating Cycle
174.18 137.79 337.31 282.77 199.55
Cash Flow Ratios
Operating Cash Flow Per Share
1.18 0.95 0.10 -0.71 -0.78
Free Cash Flow Per Share
1.17 0.95 -0.14 -0.71 -0.79
CapEx Per Share
<0.01 <0.01 0.24 0.00 <0.01
Free Cash Flow to Operating Cash Flow
0.99 1.00 -1.40 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
174.82 301.57 0.42 0.00 -112.00
Capital Expenditure Coverage Ratio
174.82 301.57 0.42 0.00 -112.00
Operating Cash Flow Coverage Ratio
3.63 3.03 0.29 -1.84 -1.95
Operating Cash Flow to Sales Ratio
0.19 0.16 0.02 -0.22 -0.26
Free Cash Flow Yield
4.83%5.17%-0.46%-4.43%-3.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.66 13.43 -83.69 -11.92 -22.31
Price-to-Sales (P/S) Ratio
3.91 3.17 7.06 4.98 7.74
Price-to-Book (P/B) Ratio
4.46 4.15 11.88 6.43 6.93
Price-to-Free Cash Flow (P/FCF) Ratio
20.72 19.34 -219.68 -22.57 -29.55
Price-to-Operating Cash Flow Ratio
20.56 19.28 307.10 -22.57 -29.81
Price-to-Earnings Growth (PEG) Ratio
0.91 -0.03 1.16 -0.43 0.54
Price-to-Fair Value
4.46 4.15 11.88 6.43 6.93
Enterprise Value Multiple
33.22 27.69 -73.68 -11.38 -21.92
Enterprise Value
3.90B 2.77B 5.00B 2.52B 3.66B
EV to EBITDA
33.22 27.69 -73.68 -11.38 -21.92
EV to Sales
3.72 2.90 6.88 4.87 7.57
EV to Free Cash Flow
19.70 17.64 -214.05 -22.11 -28.89
EV to Operating Cash Flow
19.58 17.58 299.23 -22.11 -29.15
Tangible Book Value Per Share
4.77 3.70 2.24 2.48 3.37
Shareholders’ Equity Per Share
5.43 4.42 2.64 2.48 3.37
Tax and Other Ratios
Effective Tax Rate
0.05 0.12 -0.20 -0.01 >-0.01
Revenue Per Share
6.20 5.78 4.43 3.20 3.02
Net Income Per Share
1.55 1.37 -0.37 -1.34 -1.05
Tax Burden
0.95 0.88 1.20 1.01 1.00
Interest Burden
2.65 3.06 0.70 0.95 0.98
Research & Development to Revenue
0.33 0.32 0.48 0.70 0.49
SG&A to Revenue
0.00 0.00 0.54 0.00 0.82
Stock-Based Compensation to Revenue
0.05 0.07 0.09 0.13 0.13
Income Quality
0.76 0.70 -0.27 0.53 0.75
Currency in USD